The Senate Appropriations Committee has approved the Rohrbacher-Blumenauer amendment, which protects state-approved medical cannabis programs from federal interference, as part of the 2018 Commerce, Justice and Science appropriations bill, according to a report from the Hill. Specifically, the amendment prevents the Department of Justice from using federal funds to crack down on state-legal medical cannabis programs.

The vote rebukes a request from Attorney General Jeff Sessions, who sent a letter to members of Congress last month urging them to oppose the measure.

Aaron Smith, executive director of the National Cannabis Industry Association, said it was “great to see” the committee members approve the amendment and that “now it’s time for the House to do the same.”

“Patients deserve access to care, states deserve respect, and members of the House deserve the opportunity to vote on amendments like this that have the strong support of their constituents,” Smith said in a statement, adding that, “more than 90 percent of Americans favor medical marijuana policies.”

Continue reading HERE

Originally posted by T. G. Branfalt for ganjapreneur.com